The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment
暂无分享,去创建一个
Volker Arolt | Stefan Evers | Guenter Hetzel | Andreas Erfurth | V. Arolt | A. Erfurth | S. Evers | M. Rothermundt | Gerald Ponath | Matthias Rothermundt | Olaf Moeller | O. Moeller | G. Ponath | G. Hetzel
[1] J E Christie,et al. Changes in Auditory P3 Event-related Potential in Schizophrenia and Depression , 1987, British Journal of Psychiatry.
[2] L. Kaufman,et al. The hippocampal formation as a source of the slow endogenous potentials. , 1983, Electroencephalography and clinical neurophysiology.
[3] M. Wiesmann,et al. S100B and response to treatment in major depression: a pilot study , 2003, European Neuropsychopharmacology.
[4] W. Burke,et al. Amplitude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder. , 1995, Psychopharmacology bulletin.
[5] W. Ritter,et al. The scalp topography of potentials in auditory and visual discrimination tasks. , 1977, Electroencephalography and clinical neurophysiology.
[6] R. Ihl,et al. Event-related potentials and psychopharmacology. Cholinergic modulation of P300. , 1994, Pharmacopsychiatry.
[7] O. P. Tandon,et al. A study of P300-event related evoked potential in the patients of major depression. , 1999, Indian journal of physiology and pharmacology.
[8] M. Wiesmann,et al. Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression , 2004, Neuroscience Letters.
[9] D. Souza,et al. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study , 2002, European Neuropsychopharmacology.
[10] V. Arolt,et al. S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia , 2004, Neuropsychopharmacology.
[11] J. Rohrbaugh,et al. Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events. , 1980, Science.
[12] D. Souza,et al. Increased serum S100B protein in schizophrenia: a study in medication-free patients. , 2001, Journal of psychiatric research.
[13] M. Hamilton,et al. Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.
[14] B N Gangadhar,et al. P300 amplitude in non-bipolar, melancholic depression. , 1993, Journal of affective disorders.
[15] N. Bathien,et al. Visual cognitive dysfunction in depression: an event-related potential study. , 1998, Electroencephalography and clinical neurophysiology.
[16] Á. Pascual-Leone,et al. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression , 1996, The Lancet.
[17] David Friedman,et al. Event-related potentials in depression: Influence of task, stimulus hemifield and clinical features on P3 latency , 1991, Biological Psychiatry.
[18] M. Wiesmann,et al. S-100B is increased in melancholic but not in non-melancholic major depression. , 2001, Journal of affective disorders.
[19] C. Yingling,et al. A subcortical correlate of P300 in man. , 1984, Electroencephalography and clinical neurophysiology.
[20] S. Evers,et al. Dynamic Changes of Cognitive Habituation and Serotonin Metabolism During the Migraine Interval , 1999, Cephalalgia : an international journal of headache.
[21] Stefan Evers,et al. The impact of transcranial magnetic stimulation on cognitive processing: an event-related potential study , 2001, Neuroreport.
[22] C. Nelson,et al. P300 brain activity in seizure patients preceding temporal lobectomy. , 1991, Archives of neurology.
[23] H. Grabe,et al. Neurotrophic Factor S100beta in Major Depression , 2001, Neuropsychobiology.
[24] W. Drevets,et al. The cellular neurobiology of depression , 2001, Nature Medicine.
[25] M. Wiesmann,et al. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology , 2001, Molecular Psychiatry.
[26] R. Donato,et al. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.
[27] V. Arolt,et al. S100B in brain damage and neurodegeneration , 2003, Microscopy research and technique.
[28] U Hegerl,et al. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression , 2002, Clinical Neurophysiology.
[29] S. Yamawaki,et al. Changes in auditory P300 in patients with major depression and silent cerebral infarction. , 1997, Journal of affective disorders.
[30] U Hegerl,et al. Event-related potentials: Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? , 2001 .
[31] M. Maes,et al. Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude. , 1998, Journal of affective disorders.
[32] M. Schroeter,et al. S100B is increased in mood disorders and may be reduced by antidepressive treatment , 2002, Neuroreport.